Engineering NK cell-based cancer treatments

Engineering NK cell-based cancer treatments

NK Cells: Unlocking the Potential of Natural Killer Cells in Cancer TherapyПодробнее

NK Cells: Unlocking the Potential of Natural Killer Cells in Cancer Therapy

NK cell engineering with MaxCyte®Подробнее

NK cell engineering with MaxCyte®

Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian CancerПодробнее

Cytokine Armored CAR NK Cell Therapy for Advanced Ovarian Cancer

Reprogramming Natural Killer Cells for Cancer ImmunotherapyПодробнее

Reprogramming Natural Killer Cells for Cancer Immunotherapy

Advances in gene engineering technologies for NK cell-based immunotherapyПодробнее

Advances in gene engineering technologies for NK cell-based immunotherapy

The Promise of CAR NK Cell TherapyПодробнее

The Promise of CAR NK Cell Therapy

Engineering and Reprogramming Natural Killer Cells for Immunotherapy of CancerПодробнее

Engineering and Reprogramming Natural Killer Cells for Immunotherapy of Cancer

VII Workshop LIM/31 HC-FMUSP: NK Cell-based Cancer ImmunotherapyПодробнее

VII Workshop LIM/31 HC-FMUSP: NK Cell-based Cancer Immunotherapy

FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignanciesПодробнее

FT596: iPSC-derived CAR-NK cells with engineered persistence for B-cell malignancies

Harnessing NK cells for cancer immunotherapiesПодробнее

Harnessing NK cells for cancer immunotherapies

Serum-free Expansion of NK Cells with K562- Based Feeder Systems for Clinical ApplicationsПодробнее

Serum-free Expansion of NK Cells with K562- Based Feeder Systems for Clinical Applications

Engineering iPSC-derived Natural Killer Cells for Enhanced Efficacy of Cancer TherapiesПодробнее

Engineering iPSC-derived Natural Killer Cells for Enhanced Efficacy of Cancer Therapies

Off-the-shelf NK cell therapy [WEBINAR]Подробнее

Off-the-shelf NK cell therapy [WEBINAR]

Automated manufacturing of CAR NK cells [WEBINAR]Подробнее

Automated manufacturing of CAR NK cells [WEBINAR]